Home
News
Create
Screeners
Insights
EIKO Lifesciences
51.
98
+0.62
(+1.21%)
Market Cap
₹71.35 Cr
PE Ratio
17.35
Industry
Chemicals
Buy
Sell
Company Performance:
1D
+1.21%
1M
-1.72%
6M
+6.71%
1Y
-19.15%
5Y
+52.88%
View Company Insights
Latest news about EIKO Lifesciences
Eiko Life Sciences EGM for ₹21.86 cr fundraise
Dec 12, 2025
EIKO Lifesciences Limited has scheduled an EGM for January 7, 2026, to seek approval for a ₹21.86 crore fundraising initiative through preferential allotment. The plan includes issuing 33,00,000 warrants and 6,75,000 equity shares at ₹55 each. The primary objective is to acquire a majority stake in SSM Formulations Private Limited, allocating ₹14.44 crores for this purpose. The fundraising involves both promoter and non-promoter participation, with strategic goals of portfolio expansion and market entry.
Eiko Lifesciences Acquires 51% Stake in WHO-GMP Accredited SSM Formulations
Dec 11, 2025
Eiko Life Sciences Reports 281% Surge in Q2 Profit, Revenue Up 19%
Oct 31, 2025
Eiko LifeSciences Reports Strong Q1 Results, Announces Board Changes and Capital Increase
Jul 29, 2025
Eiko LifeSciences Announces Board Changes and Expansion Plans at 48th AGM
Jul 29, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation